维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Fornier MN"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer显示文摘	Fornier MN Morris PG Abbruzzi A	2011	Ann Oncol2011，22，12：	1
2	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification 显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，：	1
3	Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate 显示文摘	Fornier MN Seidman AD Schwartz MK	2005	Ann Oncol2005，16，2：	1
4	Epothilones in breast cancer: review of clinical experience 显示文摘	FORNIER MN	2007	Ann Oncol2007，18，5：	1
5	Risk models for neutropenia in patients with breast cancer 显示文摘	Dang CT Fornier MN Hudis CA	2003	Ontology (Williston Park)2003，17，1111：	1
6	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
7	A phase I study of dasatin- ib and weekly paclitaxel for metastatic breast cancer 显示文摘	Fornier MN Morris PG Abbruzzi A	2011	Ann Oncol2011，22，12：	1
8	Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and theire analogues 显示文摘	Fornier MN	2007	Clin Brest Cancer2007，7，10：	1
9	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER-2 immunophenotype and gene amplification 显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
10	Weekly trastuzumab and paclitaxel therapy for HER2 immunophenotype and gene amplification显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
11	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplication显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
12	Incidence of chemothera- py - induced,long - term amenorrhea in patients with breast carci- noma age 40 years and younger after adjuvant anthracycline and taxane 显示文摘	Fornier MN Modi S Panageas KS	2005	Cancer2005，104，8：	1
13	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification显示文摘	Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
14	Incidence of chemotheraphy-induced long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane显示文摘	Fornier MN Modi S Panageas KS	2005	Cancer2005，104，8：	1
15	Approved agents for metastatic breast cancer显示文摘	Fornier MN	2011	Semin Oncol2011，38，2：	1
16	Microtubule active agents: beyond the taxane frontier 显示文摘	Morris PG Fornier MN	2008	Clin Cancer Res2008，14，22：	1
17	Epothilones in breast cancer: review of clinical experience显示文摘	FORNIER MN	2007	Ann Oncol2007，18，5：	1
18	Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplicationl 显示文摘	Seidman AD Fornier MN Esteva FJ	2001	J Clin Oncol2001，19，10：	1
19	Ixabepilone,first in a new class of antineoplastic agents:The natural epothilones and their analogues显示文摘	Fornier MN	2007	Clin Brest Cancer2007，7，10：	1
20	Incidence of chemotherapy-induced,long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane显示文摘	Fornier MN Modi S Panageas KS	2005	Cancer2005，104，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示